Concepedia

Vascular protease‐activated receptor 4 upregulation, increased platelet aggregation, and coronary lipid deposits induced by long‐term dabigatran administration – results from a diabetes animal model

Alina Scridon, Alina Mărginean, Adina Huţanu, Laura Chinezu, Dan Gheban, Marcel Perian, A Vântu, Doina Gherțescu, Paul Ciprian Fișcă, Răzvan Constantin Şerban,

Journal of Thrombosis and Haemostasis · 2019 · 11 citations · 38 references

DOIFull text

Open access

Concepts

References

38

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

, , +12

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2009 · 2.6K citations · Full text

, , +12

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Christopher P. Cannon, Deepak L. Bhatt, Jonas Oldgren et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

, , +17

Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism

Sam Schulman, Clive Kearon, Ajay K. Kakkar et al. · New England Journal of Medicine · 2013 · 990 citations · Full text

, , +12

Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation

David J. Graham, Marsha E. Reichman, Michael Wernecke et al. · Circulation · 2014 · 644 citations · Full text

, , +17